Investigational New Drugs

, Volume 29, Issue 2, pp 225–231 | Cite as

Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumors

  • Preeti Roy
  • Jasmine George
  • Smita Srivastava
  • Shilpa Tyagi
  • Yogeshwer ShuklaEmail author


Breast cancer has become the second leading cause of cancer-related deaths worldwide. The control of this disease can be achieved through chemoprevention, which refers to the consumption of synthetic or naturally occurring agents to block, reverse, or delay the process of tumor development. Tea (Camellia sinensis), the most widely consumed beverage, has shown promises in the field of cancer chemoprevention. Inhibition of tumorigenesis by green or black tea polyphenols has been demonstrated in various in vitro and in vivo models. Here, we examined the inhibitory effect of green tea polyphenol (GTP) and black tea polyphenol (BTP) on the development of mammary tumors- induced by 7, 12-dimethylbenz (a) anthracene (DMBA) in female, Wistar rats. 13% and 33% of animals developed tumors in GTP and BTP supplemented groups, respectively. Both GTP and BTP are effective in significantly inhibiting the cumulative number of mammary tumors (by ~92% and 77%, respectively) and in reducing their growth. Mechanistically, we investigated the effects of GTP and BTP on the components of cell signaling pathways, connecting biomolecules involved in cancer development. GTP and BTP supplementation as a sole source of drinking solution leads to scavenging of reactive oxygen species (ROS) (by ~72% and 69%, respectively) by inhibiting cyclooxygenase-2 (Cox-2) and inactivation of phosphorylated forms of nuclear factor-kappa B (NF-κB) and Akt. Altogether, the study suggests that both cultivars of tea, i.e. green and black, have anti-tumorigenic potential against DMBA-induced mammary tumorigenesis in Wistar rats. Further studies such as large and long term cohort studies and clinical trials are warranted.


Tea polyphenols Chemoprevention Mammary tumors Cyclooxygenase-2 Nuclear factor-kappa B 



Authors are thankful to Director, Indian Institute of Toxicology Research, Lucknow for his keen interest in the study and to Department of Biotechnology (India) for providing fellowship to Ms. Preeti Roy. Authors are also thankful to Indfrag Limited (Bangalore, India) for gifting tea polyphenols. The authors are thankful to CSIR, New Delhi for funding this work from Task force project NWP-17.


  1. 1.
    Agarwal G, Ramakant P, Sánchez Forgach ER, Rendón JC, Chaparro JM, Basurto CS, Margaritoni M (2009) Breast cancer care in developing countries. World J Surg [Epub ahead of print]Google Scholar
  2. 2.
    Lamartiniere CA (2002) Timing of exposure and mammary cancer risk. J Mammary Gland Biol Neoplasia 7:67–76CrossRefPubMedGoogle Scholar
  3. 3.
    Kalra N, Prasad S, Shukla Y (2005) Antioxidant potential of black tea against 7, 12-dimethylbenz(a)anthracene-induced oxidative stress in Swiss albino mice. J Environ Pathol Toxicol Oncol 24:105–114CrossRefPubMedGoogle Scholar
  4. 4.
    Cerutti PA (1985) Prooxidant states and tumor promotion. Science 227:375–381CrossRefPubMedGoogle Scholar
  5. 5.
    Xing G, Romanyukha A, Bunger R (2008) Reactive oxygen species (ROS) in human breast cancer cell lines differing in malignancy: an electron paramagnetic resonance (EPR) study. The FASEB J 22:794–710Google Scholar
  6. 6.
    Huang Q, Wu L, Tashiro S, Gao H, Onodera S, Ikejima T (2005) (+)-Catechin, an ingredient of green tea, protects Murine Microglia from oxidative stress-induced DNA damage and cell cycle arrest. J Pharmacol Sci 98:16–24CrossRefPubMedGoogle Scholar
  7. 7.
    Kim EH, Na HK, Kim DH, Park SA, Kim HN, Song NY, Surh YJ (2008) 15- Deoxy-Delta 12, 14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. Carcinogenesis 29:688–695CrossRefPubMedGoogle Scholar
  8. 8.
    Novitskii VV, Riazantseva NV, Iu Chasovskikh N, Starikova EG, Kaigorodova EV, Starikov Iu V, Filipenko ML, Boiarskikh UA (2009) The role of p53 and NF-kappaB transcription factors in redox-dependent dysregulation of mononuclear leukocyte apoptosis. Vestn Ross Akad Med Nauk 4:3–7PubMedGoogle Scholar
  9. 9.
    Biswas DK, Dezube BJ, Ahlers CM, Pardee AB (1993) Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kB action. J Acquired Immune Defic Syndr 6:778–786Google Scholar
  10. 10.
    Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ (1999) Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 274:10911–10915CrossRefPubMedGoogle Scholar
  11. 11.
    Javed S, Mehrotra NK, Shukla Y (1998) Chemopreventive effects of black tea polyphenols in mouse skin model of carcinogenesis. Biomed Env Sci 11:307–313Google Scholar
  12. 12.
    Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA (1995) Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 96:239–243CrossRefPubMedGoogle Scholar
  13. 13.
    Kalra N, Seth K, Prasad S, Singh M, Pant AB, Shukla Y (2007) Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways. Life Sci 80:2137–2146CrossRefPubMedGoogle Scholar
  14. 14.
    Costa I, Solanas M, Escrich E (2002) Histopathologic characterization of mammary neoplastic lesions induced with 7, 12 dimethylbenz(alpha)anthracene in the rat: A comparative analysis with human breast tumours. Arch Pathol Lab Med 126:915–927PubMedGoogle Scholar
  15. 15.
    Russo IH, Russo J (1996) Mammary gland neoplasia in long-term rodent studies. Environ Health Prospect 104:938–967CrossRefGoogle Scholar
  16. 16.
    Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H (2004) Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem 91:232–242CrossRefPubMedGoogle Scholar
  17. 17.
    Arora A, Siddiqui A, Shukla Y (2004) Modulation of p53 in 7, 12 dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice, Mol. Cancer Ther 3:1459–1466Google Scholar
  18. 18.
    Esposti DM, Mclennan H (1998) Mitochondria and cells produce reactive oxygen specie in virtual anaerobiosis: relevance to ceramide-induced apoptosis. FEBS Lett 430:338–342CrossRefPubMedGoogle Scholar
  19. 19.
    Moghadasian MH, Freeman HJ, Godin DV (1996) Endogenous antioxidant status in neoplastic and adjacent tissues in 1, 2- dimethylhydrazine-induced colon cancer in rats: Effects of olsalazine. Carcinogenesis 17:983–987CrossRefPubMedGoogle Scholar
  20. 20.
    Kregel KC, Zhang HJ (2007) An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 1:R18–36Google Scholar
  21. 21.
    Kim SO, Chun KS, Kundu JK, Surh YJ (2004) Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors 21:27–31CrossRefPubMedGoogle Scholar
  22. 22.
    Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 91:767–73Google Scholar
  23. 23.
    Pan MH, Ho CT (2008) Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 11:2558–2574CrossRefGoogle Scholar
  24. 24.
    Portakal O, Ozkaya O, Inal ME, Bozan B, Kosan M, Sayek I (2000) Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 33:279–284CrossRefPubMedGoogle Scholar
  25. 25.
    Jhawar RS (2000) Tea the universal health drink. UBS, New DelhiGoogle Scholar
  26. 26.
    Victor VM, Rocha M, De la Fuente M (2004) Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 4:327–347CrossRefPubMedGoogle Scholar
  27. 27.
    Viatour P, Merville M, Bours V, Chariot A (2005) Phosphorylation of NF-қB and IқB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43–52CrossRefPubMedGoogle Scholar
  28. 28.
    Yoon H, Liu R (2007) Effect of selected phytochemicals and apple extracts on NF-қB Activation in human breast cancer MCF-7 cells. J Agric Food Chem 55:3167–3173CrossRefPubMedGoogle Scholar
  29. 29.
    Kim DW, Sovak MA, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J, Sonenshein GE (2000) Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21:871–879CrossRefPubMedGoogle Scholar
  30. 30.
    Subbaramaiah K, Dannenberg AJ (2003) Cyclooxygenase-2: a molecular target for chemoprevention and treatment. Trends Pharmacol Sci 24:96–102CrossRefPubMedGoogle Scholar
  31. 31.
    Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, Liu GY, Sitthimonchai S, Frank N (2003) Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res 523-524:163–172PubMedGoogle Scholar
  32. 32.
    Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L (1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18:6013–6020CrossRefPubMedGoogle Scholar
  33. 33.
    Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donne DB (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 40:182–185Google Scholar
  34. 34.
    Craven RJ, Lightfoot H, Cance WG (2003) A decade of tyrosine kinases: from gene discovery to therapeutics. Surg Oncol 12:39–49CrossRefPubMedGoogle Scholar
  35. 35.
    Bose S, Chandran S, Mirocha JM, Bose N (2006) The Akt pathway in human breast cancer: a tissue-array-based analysis. Mod Pathol 19:238–245CrossRefPubMedGoogle Scholar
  36. 36.
    Li Y, Sarkar FH (2002) Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 8:2369–2377PubMedGoogle Scholar
  37. 37.
    Chinni SR, Sarkar FH (2002) Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 8:1228–1236PubMedGoogle Scholar
  38. 38.
    Satoh H, Nishikawa K, Suzuki K, Asano R, Virgona N, Ichikawa T, Hagiwara K, Yano T (2003) Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent. Res Commun Mol Pathol Pharmacol 113-4:149–158Google Scholar
  39. 39.
    Li HL, Ye KH, Ren XD (2001) Heparin induced apoptosis in human nasopharyngeal carcinoma CNE2 cells. Cell Res 11:311–315CrossRefPubMedGoogle Scholar
  40. 40.
    Li HL, Chen DD, Li XH, Zhang HW, Lu YQ, Ye CL, Ren XD (2002) Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species. World J Gastroenterol 3:431–435Google Scholar
  41. 41.
    Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480–481:243–268PubMedGoogle Scholar
  42. 42.
    Lahiry L, Saha B, Chakraborty J, Bhattacharyya S, Chattopadhyay S, Banerjee S, Choudhuri T, Mandal D, Bhattacharyya A, Sa G, Das T (2008) Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis. Apoptosis 13:771–781CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Preeti Roy
    • 1
  • Jasmine George
    • 1
  • Smita Srivastava
    • 1
  • Shilpa Tyagi
    • 1
  • Yogeshwer Shukla
    • 1
    Email author
  1. 1.Proteomics Laboratory, Indian Institute of Toxicology ResearchCSIRLucknowIndia

Personalised recommendations